Drawing for ACLARA

USPTO serial 78347771

ACLARA

Reviewed by CopyMark Law Group

Reg. 2985144Status 710
Filing date
Status date
Registration date
Aug 16, 2005
Examiner
SOUDERS, MICHAEL J
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ACLARA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Barry J. Parker

Goods and services

ClassDescriptionStatusFirst use
001Chemical reagents and assays for scientific or research useSECTION 8 - CANCELLEDDec 3, 2002
005chemical reagents and assays for clinical or medical laboratory useSECTION 8 - CANCELLEDDec 3, 2002
009Computer software for gene and protein expression data analysis and reports (date of first use anywhere-- 04/09/2002; date of first use in commerce-- 04/09/2002); photoactivation illuminator device for labeling, detecting and identifying proteins (date of first use anywhere-- 08/00/2002; date of first use in commerce-- 08/00/2002)SECTION 8 - CANCELLED—
042Design and development of gene and protein expression assays; industrial analysis and research services, namely, providing scientific facilities, equipment, software, reagents and assays for gene and protein expression analysis and research; collaborative research in the development of a wide variety of pharmaceuticals, medical diagnostic tests and drug therapiesSECTION 8 - CANCELLEDJun 18, 2003

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 5, 2012C8..CANCELLED SEC. 8 (6-YR)—
Aug 16, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 24, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 4, 2005NPUBNOTICE OF PUBLICATION—
Feb 1, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 22, 2004ALIEASSIGNED TO LIE—
Nov 16, 2004TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 16, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 1, 2004TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 1, 2004ACECAMENDMENT FROM APPLICANT ENTERED—
Sep 27, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 27, 2004TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 8, 2004EMRVEMAIL RECEIVED—
Sep 1, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 29, 2004CPEAEXAMINER'S AMENDMENT AND/OR PRIORITY ACTION MAILED—
Jul 28, 2004DOCKASSIGNED TO EXAMINER—
Jan 12, 2004NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance